Ionis Pharmaceuticals IONS Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $173.38M-53.4% | $372.26M+10.0% | $338.34M+13.8% | $297.3M+12.5% | $264.19M+9.1% | ||
| $1.12B-29.2% | $1.58B+23.1% | $1.28B-3.5% | $1.33B+7.8% | $1.23B-12.1% | ||
| $5.56M-44.7% | $10.05M-4.0% | $10.47M+23.5% | $8.48M-26.3% | $11.5M-8.1% | ||
| $2.94B-1.8% | $2.99B+18.7% | $2.52B-2.3% | $2.58B+6.5% | $2.42B-7.7% | ||
| $142.4M+15.7% | $123.05M+16.0% | $106.12M-5.2% | $111.95M+8.8% | $102.93M+9.2% | ||
| —— | —— | —— | —— | —— | ||
| $3.45B-2.1% | $3.52B+16.2% | $3.03B+1.6% | $2.99B+6.1% | $2.81B-6.3% | ||
| $26.03M-7.3% | $28.08M+96.0% | $14.33M-37.2% | $22.8M+30.6% | $17.46M-59.4% | ||
| $69.2M-6.2% | $73.76M-4.2% | $76.99M+1.4% | $75.91M-6.4% | $81.1M+2.7% | ||
| $432.5M— | —— | —— | —— | —— | ||
| $716.59M-8.3% | $781.57M-13.5% | $903.46M+0.7% | $897.24M+258% | $250.29M-19.1% | ||
| $2.96B-2.5% | $3.03B+25.7% | $2.42B+2.6% | $2.35B+0.7% | $2.34B-3.2% | ||
| 300M0.0% | 300M0.0% | 300M0.0% | 300M0.0% | 300M0.0% | ||
| -$2.72B-3.5% | -$2.63B-9.6% | -$2.4B-5.7% | -$2.27B+5.2% | -$2.4B-6.5% | ||
| $491.41M+0.5% | $489.09M-20.9% | $617.97M-2.2% | $631.72M+32.8% | $475.73M-19.1% | ||
| $3.45B-2.1% | $3.52B+16.2% | $3.03B+1.6% | $2.99B+6.1% | $2.81B-6.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Ionis Pharmaceuticals's total assets?
- Ionis Pharmaceuticals (IONS) holds $3.4B in total assets, up 22.7% year over year.
- How much debt does Ionis Pharmaceuticals have?
- Ionis Pharmaceuticals carries $691.7M in total debt against $491.4M of shareholders' equity, a debt-to-equity ratio of 1.41.
- How much cash does Ionis Pharmaceuticals have?
- Ionis Pharmaceuticals holds $173.4M in cash and equivalents.
- Can Ionis Pharmaceuticals cover its short-term obligations?
- Its current ratio is 4.10 — current assets exceed current liabilities.
- Where does Ionis Pharmaceuticals's balance sheet data come from?
- Every line is extracted from Ionis Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
